NASDAQ:SPRB

Spruce Biosciences, Inc.

Stock

USD

Last Close

0.46

30/08 20:00

Market Cap

22.53M

Beta: 2.31

Volume Today

148.45K

Avg: 195.39K

PE Ratio

−3.03

PFCF: −4.30

Overview Analysis Financials Filings people Ownership API Chart Data

Income Statement Balance Sheet Cash Flow Key Metrics Ratios

Excel Tearsheet

Quarterly

Yearly

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe Now Help

	Dec '18	Dec '19	Dec '20	Dec '21	Dec '22	Dec '23
net income	-9.86M -	-13.09M 32.77%	-29.54M 125.70%	-42.29M 43.17%	-46.18M 9.19%	-47.92M 3.77%
depreciation and amortization	1K -	12K 1,100%	36K 200%	68K 88.89%	74K 8.82%	70K 5.41%
deferred income tax		-446K -		121K -		-1.91M -
stock based compensation	101K -	196K 94.06%	755K 285.20%	3.96M 424.24%	3.63M 8.26%	4.62M 27.29%
change in working capital	1.19M -	263K 77.82%	1.16M 342.21%	1.96M 68.10%	1.13M 42.10%	10.36M 814.84%
accounts receivables
inventory
accounts payables	1.70M -	-226K 113.32%	3.73M 1,751.77%	1.15M 69.22%	-1.40M 221.58%	1.91M 236.44%
other working capital	-511K -	489K 195.69%	-2.57M 625.56%	806K 131.36%	2.53M 213.77%	8.45M 234.12%
other non cash items		446K -	66K 85.20%	313K 374.24%	-340K 208.63%	1.50M 541.76%
net cash provided by operating activities	-8.57M -	-12.62M 47.22%	-27.52M 118.11%	-35.88M 30.37%	-41.68M 16.18%	-33.27M 20.17%
investments in property plant and equipment		-4K -	-74K 1,750%	-93K 25.68%	-8K 91.40%	-7K 12.50%
acquisitions net					-23.70M -
purchases of investments				-79.08M -	-36.80M 53.46%	-11.88M 67.71%
sales maturities of investments				121K -	60.50M 49,900%	67.67M 11.84%
other investing activites				-121K -	23.70M 19,686.78%
net cash used for investing activites		-4K -	-74K 1,750%	-79.17M 106,883.78%	23.69M 129.93%	55.78M 135.43%
debt repayment				-4.77M -		-1.62M -
common stock issued		12.43M -	96.25M 674.19%	423K 99.56%	2K 99.53%	51.07M 2,553,550%
common stock repurchased				134K -	76K 43.28%	169K 122.37%
dividends paid				-423K -		-169K -
other financing activites		12.43M -	84.78M 581.89%	5.28M 93.77%	-319K 106.04%	-480K 50.47%
net cash used provided by financing activities		12.43M -	181.03M 1,356.08%	643K 99.64%	-241K 137.48%	49.14M 20,490.04%
effect of forex changes on cash
net change in cash	-8.57M -	-188K 97.81%	153.44M 81,718.09%	-114.40M 174.56%	-18.23M 84.06%	71.64M 492.91%
cash at beginning of period	12.68M -	4.11M 67.58%	3.92M 4.57%	157.37M 3,910.35%	42.96M 72.70%	24.70M 42.50%
cash at end of period	4.11M -	3.92M 4.57%	157.37M 3,910.35%	42.96M 72.70%	24.73M 42.44%	96.34M 289.53%
operating cash flow	-8.57M -	-12.62M 47.22%	-27.52M 118.11%	-35.88M 30.37%	-41.68M 16.18%	-33.27M 20.17%
capital expenditure		-4K -	-74K 1,750%	-93K 25.68%	-8K 91.40%	-7K 12.50%
free cash flow	-8.57M -	-12.62M 47.27%	-27.59M 118.63%	-35.97M 30.36%	-41.69M 15.90%	-33.28M 20.17%

All numbers in USD (except ratios and percentages)